Biodesign Center for Immunotherapy
GPTKB entity
Properties (46)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Research_Institute
|
| gptkbp:aimsTo |
Enhance immune response
Develop innovative treatments |
| gptkbp:collaboratesWith |
Various academic institutions
|
| gptkbp:conducts |
Clinical trials
|
| gptkbp:conductsResearchOn |
Gene therapy
Monoclonal antibodies Cellular therapies |
| gptkbp:develops |
Therapeutic_vaccines
|
| gptkbp:engagesIn |
Translational research
|
| gptkbp:establishedIn |
2013
|
| gptkbp:focusesOn |
Immunotherapy
|
| gptkbp:hasCollaborationsWith |
Government agencies
International research institutions Pharmaceutical companies |
| gptkbp:hasPrograms |
Infectious diseases
Cancer immunology Community education Autoimmunity |
| gptkbp:hasPublications |
Numerous scientific papers
|
| gptkbp:hasResearchInterest |
Vaccine development
Immuno-oncology Tumor immunology |
| gptkbp:historicalResearch |
Immunological responses
|
| https://www.w3.org/2000/01/rdf-schema#label |
Biodesign Center for Immunotherapy
|
| gptkbp:isDedicatedTo |
Advancing immunotherapy
|
| gptkbp:isEngagedIn |
Public-private partnerships
|
| gptkbp:isFocusedOn |
Personalized medicine
|
| gptkbp:isInvolvedIn |
Public health initiatives
Clinical education |
| gptkbp:isKnownFor |
Cutting-edge research
|
| gptkbp:isPartOf |
gptkb:Biodesign_Institute
Global health initiatives |
| gptkbp:isRecognizedFor |
Innovative research
|
| gptkbp:isSupportedBy |
Grants
Private donations |
| gptkbp:ledTo |
gptkb:Dr._Raymond_L._Erikson
|
| gptkbp:locatedIn |
gptkb:Arizona_State_University
|
| gptkbp:offers |
Educational programs
Internships |
| gptkbp:participatesIn |
Conferences
|
| gptkbp:partnerships |
Biotech_companies
|
| gptkbp:provides |
Consultation services
|
| gptkbp:receivesFundingFrom |
gptkb:National_Institutes_of_Health
|
| gptkbp:supports |
Cancer research
|
| gptkbp:utilizes |
Cutting-edge technology
|